NCT07890675Recruiting
Danang Cerebral Venous Thrombosis Registry
A Prospective Registry of Patients With Cerebral Venous Thrombosis at Da Nang Hospital: Clinical Characteristics, Imaging Manifestations, and Functional Outcomes
Source: ClinicalTrials.gov · Last updated 26 Oct 2026
Brief summary (registry, in English)
Cerebral venous thrombosis (CVT) is an uncommon but potentially life-threatening type of stroke, predominantly affecting young adults and women. Although prompt diagnosis and anticoagulant therapy can lead to favorable outcomes, data regarding the clinical spectrum, neuroimaging patterns, risk factors, and long-term functional recovery of CVT patients in central Vietnam remain limited. This prospective observational study aims to establish a hospital-based registry to investigate the clinical characteristics, neuroimaging features, etiology, and treatment outcomes of patients diagnosed with cerebral venous thrombosis at Danang Hospital. All consecutive patients with confirmed CVT admitted to Danang Hospital are enrolled and managed according to standard clinical protocols. Participants are monitored throughout their hospital stay to assess acute manifestations, imaging abnormalities on computed tomography (CT), computed tomography venography (CTV), magnetic resonance imaging (MRI), or magnetic resonance venography (MRV), and inpatient complications. Functional outcomes and recovery are evaluated at hospital discharge and during follow-up using the modified Rankin Scale (mRS).
- Status (registry)
- Recruiting
- Study type
- Observational
- Enrollment
- 110 (estimated)
- First submitted
- 16 Oct 2026
- Start date
- 9 Oct 2025
- Primary completion date
- 9 Oct 2028
- Lead sponsor
- Da Nang Hospital
- Diseases
- Stroke
- NCT number
- NCT07890675
What you commit to
- Study type: Observational
- Planned participants: 110
- From 9 Oct 2025 to the primary completion date, 9 Oct 2028
- 1 site in 1 country
- Visits and tests: ask the trial team, the registry does not list them
Built from the registry fields of ClinicalTrials.gov. It describes the study, not your situation.
Who cannot take part
Copied verbatim from ClinicalTrials.gov and grouped by topic. Only the trial team decides who can take part.
Prior treatment
- Pre-existing advanced terminal illness or severe co-morbid condition with a life expectancy of less than 6 months prior to CVT presentation (e.g., end-stage malignancy, advanced organ failure).
Other illness
- Non-thrombotic occlusion of cerebral veins or sinuses (e.g., direct tumor invasion, vascular malformation, or extrinsic mechanical compression without thrombosis).
- pre-stroke modified Rankin Scale (mRS) score ≥ 2
Other
- Inability or refusal of the patient or their legal representative to complete the 6-month follow-up assessment.
- Refusal to provide informed consent.
Who the study is looking for
- Age 18 years or older.
- Definite diagnosis of cerebral venous thrombosis (CVT) confirmed by neuroimaging, including computed tomography venography (CTV), magnetic resonance venography (MRV), or digital subtraction angiography (DSA).
- Admitted to Danang Hospital for acute or subacute management.
- Patient or legally authorized representative provides written informed consent to participate in the registry.
Age in the registry: 18 years to - · Sex: All · Does not accept healthy volunteers
Sites (1)
Sites in registry order. Pick your city on the disease page to sort them by distance.
| Site | City | Country | Site status |
|---|---|---|---|
| Da Nang Hospital Coordinator of this site? Confirm its status | Da Nang | Vietnam | Recruiting |
This page is information, not medical advice. Discuss any trial with your doctor.